Condition: Carotid Atherosclerosis · Sponsor: Washington University School of Medicine
: Use of novel radio-pharmaceutical 64CUDOTA-ECL1i to evaluate arterial atherosclrosis
This description comes directly from the study's public registry record.
Kitty Harrison, BSN, RN · 314-747-0183 · harrisonk@mir.wustl.edu
Robert Gropler, M.D. · 314-747-0183 · groplerr@mir.wustl.edu
Always discuss trial participation with your own doctor first.
| Washington University CCIR | St Louis, Missouri, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04537403